Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country

References

• AbouZahr C. 2003. Global burden of maternal death and disability. Br Med Bull. 67:1–11.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. 2002. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 77:67–75.
   PubMed Web of Science ®Google Scholar
• Aggarwal PK, Jain V, Sakhuja V, Karumanchi SA, Jha V. 2006. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int. 69:621–624.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmed A. 2004. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 95:884–891.
   PubMed Web of Science ®Google Scholar
• Benyo DF, Miles TM, Conrad KP. 1997. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 82:1582–1588.
   PubMed Web of Science ®Google Scholar
• Bermudez OI, Tucker KL. 2003. Trends in dietary patterns of Latin American populations. Cadernos de saude publica/Ministerio da Saude, Fundacao Oswaldo Cruz. Escola Nacional de Saude Publica. 19 Suppl 1: S87–S99.
   PubMedGoogle Scholar
• Burton GJ, Woods AW, Jauniaux E, Kingdom JC. 2009. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 30:473–482.
   PubMed Web of Science ®Google Scholar
• Cekmen MB, Erbagci AB, Balat A, Duman C, Maral H, Ergen K, Ozden M, Balat O, Kuskay S. 2003. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin Biochem. 36:575–578.
   PubMed Web of Science ®Google Scholar
• De Wolf F, Brosens I, Robertson WB. 1982. Ultrastructure of uteroplacental arteries. Contrib Gynecol Obstet. 9:86–99.
   Google Scholar
• Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE. 2008. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet. 102:146–151.
   PubMed Web of Science ®Google Scholar
• Druzin ML, Charles B, Johnson AL. 2008. Editorial summary of symposium on hypertensive disorders of pregnancy. Curr Opin Obstet Gynecol. 20:91.
   Google Scholar
• Ganzevoort W, Rep A, Bonsel GJ, de Vries JI, Wolf H. 2004. Plasma volume and blood pressure regulation in hypertensive pregnancy. J Hypertens. 22:1235–1242.
   PubMed Web of Science ®Google Scholar
• Garcia RG, Celedon J, Sierra-Laguado J, Alarcon MA, Luengas C, Silva F, Arenas-Mantilla M, Lopez-Jaramillo P. 2007. Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 20:98–103.
   PubMed Web of Science ®Google Scholar
• Herrera JA, Parra B, Herrera E, Botero JE, Arce RM, Contreras A, Lopez-Jaramillo P. 2007. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. J Hypertens. 25:1459–1464.
   PubMedGoogle Scholar
• Hung TH, Skepper JN, Burton GJ. 2001. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol. 159:1031–1043.
   PubMed Web of Science ®Google Scholar
• Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. 2006. WHO analysis of causes of maternal death: A systematic review. Lancet. 367:1066–1074.
   PubMed Web of Science ®Google Scholar
• Kita N, Mitsushita J. 2008. A possible placental factor for preeclampsia: sFlt-1. Curr Med Chem. 15:711–715.
   PubMed Web of Science ®Google Scholar
• Kulkarni AV, Mehendale SS, Yadav HR, Kilari AS, Taralekar VS, Joshi SR. 2010. Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens Res. 33:561–567.
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS. 2009. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 22:1021–1038.
   PubMed Web of Science ®Google Scholar
• Lee H, Park H, Kim YJ, Kim HJ, Ahn YM, Park B, Park JH, Lee BE. 2005. Expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: Possible implications in the process of trophoblast apoptosis. Placenta. 26:226–233.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA. 2006. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 355:992–1005 CPEP Study Group.
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo P, Pradilla LP, Castillo VR, Lahera V. 2007. Socioeconomic pathology as a cause of regional differences in the prevalence of metabolic syndrome and pregnancy-induced hypertension. Rev Esp Cardiol. 60:168–178.
   Google Scholar
• Lopez-Jaramillo P, Herrera JA, Arenas-Mantilla M, Jauregui IE, Mendoza MA. 2008. Subclinical infection as a cause of inflammation in preeclampsia. Am J Therapeut. 15:373–376.
   PubMed Web of Science ®Google Scholar
• Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. 1994. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 101:669–674.
   PubMedGoogle Scholar
• Ministerio de la protección social. 2009. Panorama de la mortalidad materna en Colombia, 1995–2000: Logros, fracasos, compromisos y retos (parte II), Boletín epidemiológico semanal SIVIGILA Instituto Nacional De Salud.
   Google Scholar
• Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigo JJr. 2010. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res. 33:892–898.
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program. 2000. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 183:S1–S22.
   PubMed Web of Science ®Google Scholar
• Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I. 2006. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol.. 291:R1085–R1093.
   PubMed Web of Science ®Google Scholar
• Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. 1991. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol. 98:648–655.
   PubMedGoogle Scholar
• Qiu C, Phung TT, Vadachkoria S, Muy-Rivera M, Sanchez SE, Williams MA. 2006. Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia. Physiol Res/Academia Scientiarum Bohemoslovaca. 55:491–500.
   PubMed Web of Science ®Google Scholar
• Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. 2012. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 125:911–919.
   PubMed Web of Science ®Google Scholar
• Ray JG, Diamond P, Singh G, Bell CM. 2006. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG Int J Obstet Gynaecol. 113:379–386.
   PubMed Web of Science ®Google Scholar
• Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JNJr, Bennett WA. 1999. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 181:915–920.
   PubMed Web of Science ®Google Scholar
• Robinson CJ, Johnson DD, Chang EY, Armstrong DM, Wang W. 2006. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol. 195:255–259.
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. 2008. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 21:9–23.
   PubMed Web of Science ®Google Scholar
• Sanchez SE, Williams MA, Muy-Rivera M, Qiu C, Vadachkoria S, Bazul V. 2005. A case–control study of oxidized low density lipoproteins and preeclampsia risk. Gynecol Endocrinol. 21:193–199.
   PubMed Web of Science ®Google Scholar
• Sankaralingam S, Xu Y, Sawamura T, Davidge ST. 2009. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: Role for peroxynitrite. Hypertension. 53:270–277.
   PubMedGoogle Scholar
• Shokry M, Bedaiwy MA, Fathalla MM, Alsemary A, Elwakil S, Murphy A. 2010. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia. Acta Obstet Gynecol Scand. 89:143–146.
   PubMed Web of Science ®Google Scholar
• Sibai BM. 2003. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 102:181–192.
   PubMed Web of Science ®Google Scholar
• Srinivas SK, Larkin J, Sammel MD, Appleby D, Bastek J, Andrela CM, Ofori E, Elovitz MA. 2010. The use of angiogenic factors in discriminating preeclampsia: Are they ready for prime time?. J Matern Fetal Neonatal Med. 23:1294–1300.
   PubMed Web of Science ®Google Scholar
• Varughese B, Bhatla N, Kumar R, Dwivedi SN, Dhingra R. 2010. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia. Natl Med J India. 23:77–81.
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. 2006. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 12:642–649.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H. 2010. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 202:161e1–161e11.
   Web of Science ®Google Scholar
• von Dadelszen P, Magee LA, Roberts JM. 2003. Subclassification of preeclampsia. Hypertens Pregnancy. 22:143–148.
   PubMed Web of Science ®Google Scholar
• Wang A, Rana S, Karumanchi SA. 2009. Preeclampsia: The role of angiogenic factors in its pathogenesis. Physiology (Bethesda, Md.). 24:147–158.
   PubMed Web of Science ®Google Scholar
• Witztum JL. 1993. Susceptibility of low-density lipoprotein to oxidative modification. Am J Med. 94:347–349.
   PubMed Web of Science ®Google Scholar